Role of cholinergic innervation and RGS2 in atrial arrhythmia

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Jones, Douglas L ^a,b   Tuomi, Jari M ^a,c   Chidiac, Peter ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Arrhythmia; Atrial fibrillation; Autonomic nervous system; Cholinergic; Heart; Intrinsic cardiac autonomic nervous system; M3 muscarinic receptor; RGS proteins

Indexed keywords

EID: 84866391947     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00239     Document Type: Article

References (141)

1. Abramow-Newerly, M., Roy, A. A., Nunn, C., and Chidiac, P. (2006). RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell. Signal. 18, 579-591.
2. Alessi, R., Nusynowitz, M., Abildskov, J. A., and Moe, G. K. (1958). Nonuni-form distribution of vagal effects on the atrial refractory period. Am. J. Physiol. 194, 406-410.
3. Allessie, M. A., Boyden, P. A., Camm, A. J., Kleber, A. G., Lab, M. J., Legato, M. J., Rosen, M. R., Schwartz, P. J., Spooner, P. M., Van Wagoner, D. R., and Waldo, A. L. (2001). Pathophys-iology and prevention of atrial fibrillation. Circulation 103, 769-777.
4. Allessie, M. A., Lammers, W., and Bonke, F. (1985). "Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation," in Cardiac Electrophysiology and Arrhythmias, eds D. P. Zipes and J. Jarife (New York, NY: Grune & Stratton Inc.), 265-275.
5. Arora, R. C., Waldmann, M., Hopkins, D. A., and Armour, J. A. (2003). Porcine intrinsic cardiac ganglia. Anat. Rec. 271A, 249-258.
6. Bagwe, S., Berenfeld, O., Vaidya, D., Morley, G. E., and Jalife, J. (2005). Altered right atrial excitation and propagation in connexin 40 knockout mice. Circulation 112, 2245-2253.
7. Bansal, G., Druey, K. M., and Xie, Z. (2007). R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol. Ther. 116, 473-495.
8. Beazely, M. A., and Watts, V. J. (2006). Regulatory properties of adenylate cyclases type 5 and 6: a progress report. Eur. J. Pharmacol. 535, 1-12.
9. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W B., and Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98, 946-952.
10. Bers, D. M. (2004). Macromolecular complexes regulating cardiac ryan-odine receptor function. J. Mol. Cell. Cardiol. 37, 417-429.
11. Burger, D. E., Lu, X., Lei, M., Xiang, F. L., Hammoud, L., Jiang, M., Wang, H., Jones, D. L., Sims, S. M., and Feng, Q. (2009a). Neuronal nitric oxide synthase protects against myocar-dial infarction-induced ventricular arrhythmia and mortality in mice. Circulation 120, 1345-1354.
12. Burger, D. E., Xiang, F. L., Hammoud, L., Jones, D. L., and Feng, Q. (2009b). Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase. J. Pharmacol. Exp. Ther. 329, 900-907.
13. Cardinal, R., Page, P., Vermeulen, M., Ardell, J. L., and Armour, J. A. (2009). Spatially divergent cardiac responses to nicotinic stimulation of ganglionated plexus neurons in the canine heart. Auton. Neurosci. 145, 55-62.
14. Chang, C. M., Wu, T. J., Zhou, S., Doshi, R. N., Lee, M. H., Ohara, T., Fishbein, M. C., Karagueuzian, H. S., Chen, P. S., and Chen, L. S. (2001). Nerve sprouting and sympathetic hyperin-nervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation 103, 22-25.
15. Chen, F., Spicher, K., Jiang, M., Birn-baumer,L.,andWetzel, G. T. (2001). Lack of muscarinic regulation of Ca(2+) channels in G(i2)alpha gene knockout mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 280, H1989-H1995.
16. Cifelli, C., Rose, R. A., Zhang, H., Voigtlaender-Bolz, J., Bolz, S. S., Backx, P. H., and Heximer, S. P. (2008). RGS4 Regulates parasympa-thetic signaling and heart rate control in the sinoatrial node. Circ. Res. 103, 527-535.
17. Cladman, W., and Chidiac, P. (2002). Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i). Mol. Pharmacol. 62, 654-659.
18. Clark, R. B., Mangoni, M. E., Lueger, A., Couette, B., Nargeot, J., and Giles, W. R. (2004). A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am. J. Physiol. Heart Circ. Physiol. 286, H1757-H1766.
19. Connolly, M.S., and Lynch, C.B. (1981). Circadian variation of strain differences in body temperature and activity in mice. Physiol. Behav. 27, 1045-1049.
20. Coumel, P., Attuel, P., Lavallee, J., Flam-mang, D., Leclercq, J. F., and Slama, R. (1978).Theatrialarrhythmiasyn-drome of vagal origin. Arch. Mal. CoeurVaiss. 71, 645-656.
21. Danik, S. B., Liu, F., Zhang, J., Suk, H. J., Morley, G. E., Fishman, G. I., and Gutstein, D. E. (2004). Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ. Res. 95, 1035-1041.
22. Dobrev, D., and Nattel, S. (2011). New insights into the molecular basis of atrial fibrillation: mechanistic and therapeutic implications. Cardiovasc. Res. 89, 689-691.
23. Doupnik, C. A., Xu, T., and Shinaman, J. M. (2001). Profile of RGS expression in single rat atrial myocytes. Biochim. Biophys. Acta 1522, 97-107.
24. Dries, D. L., Exner, D. V., Gersh, B. J., Domanski, M. J., Waclawiw, M. A., and Stevenson, L. W. (1998). Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J. Am. Coll. Cardiol. 32, 695-703.
25. Dupont, E., Ko, Y., Rothery, S., Coppen, S. R., Baghai, M., Haw, M., and Severs, N. J. (2001a). The gap-junctional protein connexin 40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 103, 842-849.
26. Dupont, E., Matsushita, T., Kaba, R. A., Vozzi, C., Coppen, S. R., Khan, N., Kaprielian, R., Yacoub, M. H., and Severs, N. J. (2001b). Altered connexin expression in human congestive heart failure. J. Mol. Cell. Cardiol. 33,359-371.
27. Efimov, I. R., and Fedorov, V. V. (2005). Chessboard of atrial fibrillation: reentry or focus? Single or multiple source(s)? Neurogenic or myogenic? Am. J. Physiol. Heart Circ. Physiol. 289, H977-H979.
28. Fabritz, L., Kirchhof, P., Fortmuller, L., Auchampach, J. A., Baba, H. A., Breithardt, G., Neumann, J., Boknik, P., and Schmitz, W. (2004). Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adeno-sine receptors. Cardiovasc. Res. 62, 500-508.
29. Fisher, J. T., Vincent, S. G., Gomeza, J., Yamada,M.,and Wess,J. (2004).Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J. 18, 711-713.
30. Fu, Y., Huang, X., Piao, L., Lopatin, A. N., and Neubig, R. R. (2007). Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. Am. J. Physiol. Heart Circ. Physiol. 292, H2532-H2539.
31. Fu, Y., Huang, X., Zhong, H., Mortensen, R. M., D'Alecy, L. G., and Neubig, R. R. (2006). Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. Circ. Res. 98, 659-666.
32. Furness, J. B., Jones, C., Nurgali, K., and Clerc, N. (2004). Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog. Neurobiol. 72, 143-164.
33. Fuster, V., Ryden, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W W., Levy, S., McNa-mara, R. L., Prystowsky, E. N., Wann, L. S., Wyse, D. G., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Gregoratos, G., Hiratzka, L. F., Jacobs, A. K., Russell, R. O., Smith, S. C. Jr., Klein, W. W., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De, B. G., Flather, M., Hradec, J.,Oto, A., Parkhomenko, A., Silber, S., and Torbicki, A. (2001). ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104, 2118-2150.
34. Garrey, W. E. (1914). The nature of fibrillary contraction of the heart. Its relations to tissue mass and form. Am. J. Physiol. 33, 397-414.
35. Garrey, W E. (1924). Auricular fibrillation. Physiol. Rev. 4, 215-250.
36. Gollob, M. H., Jones, D. L., Krahn, A. D., Danis, L., Gong, X. Q., Shao, Q., Liu, X., Veinot, J. P., Tang, A. S., Stewart, A. F., Tesson, F., Klein, G. J., Yee, R., Skanes, A. C., Guiraudon, G. M., Ebi-hara, L. and Bai, D. (2006). Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 354, 2677-2688.
37. Gross, V., Tank, J., Obst, M., Plehm, R., Blumer, K. J., Diedrich, A., Jordan, J., and Luft, F. C. (2005). Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1134-R1142.
38. Gu,S., Cifelli, C., Wang, S., and Heximer, S. P. (2009). RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin. Sci. (Lond.) 116, 391-399.
39. Gutstein, D. E., Morley, G. E., Tamad-don, H., Vaidya, D., Schneider, M. D., Chen, J., Chien, K. R., Stuhlmann, H., and Fishman, G. I. (2001). Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 88, 333-339.
40. Haissaguerre, M., Jais, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Metayer, P., and Clementy, J. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659-666.
41. Haissaguerre, M., Shah, D. C., Jais, P., Hocini, M., Yamane, T., Deisenhofer, I., Garrigue, S., and Clementy, J. (2000). Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am. J. Cardiol. 86, 9K-19K.
42. Hashimoto, N., Yamashita, T., and Tsu-ruzoe, N. (2006). Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation. Pharmacol. Res. 54, 136-141.
43. Hassall, C. J., and Burnstock, G. (1987). Immunocytochemical localisation of neuropeptide Y and 5-hydroxytryptamine in a subpopu-lation of amine-handling intracar-diac neurones that do not contain dopamine beta-hydroxylase in tissue culture. Brain Res. 422, 74-82.
44. Hellgren, I., Mustafa, A., Riazi, M., Suli-man, I., Sylven, C., and Adem, A. (2000). Muscarinic M3 receptor subtype gene expression in the human heart. Cell Mol. LifeSci. 57,175-180.
45. Heximer, S. P., Knutsen, R. H., Sun, X., Kaltenbronn, K. M., Rhee, M. H.,Peng,N.,Oliveira-dos-Santos,A., Penninger, J. M., Muslin, A. J., Steinberg, T. H., Wyss, J. M., Mecham, R. P., and Blumer, K. J. (2003). Hypertension and prolonged vasoconstrictor signalingin RGS2-deficient mice. J. Clin. Invest. 111, 445-452.
46. Heximer, S. P., Srinivasa, S. P., Bernstein, L. S., Bernard, J. L., Linder, M. E., Hepler, J. R., and Blumer, K. J. (1999). G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. 274, 34253-34259.
47. Hoffa, M., and Ludwig, C. (1850). Einge neueversuche uber herzbewe-gung. Zeitschrift Rationellen Medizin 9,107-144.
48. Ingi, T., Krumins, A. M., Chidiac, P., Brothers, G. M., Chung, S., Snow, B. E., Barnes, C. A., Lanahan, A. A., Siderovski, D. P., Ross, E. M., Gilman, A. G., and Worley, P. F. (1998). Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J. Neurosci. 18, 7178-7188.
49. Jalife, J. (2003). Rotors and spiral waves in atrial fibrillation. J. Cardiovasc. Electrophysiol. 14, 776-780.
50. Jalife, J., Berenfeld, O., Skanes, A., and Mandapati, R. (1998). Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? J. Cardiovasc. Electrophysiol. 9(Suppl. 8),S2-S12.
51. Jalife, J., and Pandit, S. V. (2005). Ionic mechanisms of wavebreak in fibrillation. Heart Rhythm 2, 660-663.
52. Jones, D. L., Guiraudon, G. M., Skanes, A. C., and Guiraudon, C. M. (2008a). Anatomical pitfalls during encircling cryoablation of the left atrium for atrial fibrillation therapy in the pig. J. Interv. Card. Electrophysiol. 21, 187-193.
53. Jones, D. L., Tuomi, J., Ramsay, D., Guiraudon, C. M., Cardinal, R., Page, P., and Guiraudon, G. M. (2008b). Left atrial neuroablation for atrial fibrillation therapy: a feasibility study. J. Interv. Card. Electro Physiol. 21, 171-172.
54. Jones, D. L., Petrie, J. P., and, Li, H. G. (2001). Spontaneous, electrically, and cesium chloride induced arrhythmia and afterdepolarizations in the rapidly paced dog heart. Pacing Clin. Electrophysiol. 24(Pt 1), 474-485.
55. Jones, D. L., Tuomi, J., Ramsay, D., Guiraudon, C. M., Armour, J. A., Cardinal, R., Page, P., and Guiraudon, G. M. (2007). Left atrial neuroablation for atrial fibrillation: a feasibility study. Can. J. Cardiol. 23, 225C.
56. Kalifa, J., Jalife, J., Zaitsev, A. V., Bagwe, S., Warren, M., Moreno, J., Berenfeld, O., and Nattel, S. (2003). Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 108, 668-671.
57. Kang, D., Han, J., and Kim, D. (2006). Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor. Am. J. Physiol. Cell Physiol. 291, C649-C656.
58. Kannel, W. B., Abbott, R. D., Savage, D. D., and McNamara, P. M. (1982). Epidemiologic features of chronic atrial fibrillation: the Fram-ingham study. N. Engl. J. Med. 306, 1018-1022.
59. Karakoula, A., Tovey, S. C., Brighton, P. J., and Willars, G. B. (2008). Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11. Eur. J. Pharmacol. 587, 16-24.
60. Kirchhof, P., Fabritz, L., Fortmuller, L., Matherne, G. P., Lankford, A., Baba, H. A., Schmitz, W., Brei-thardt, G., Neumann, J., and Boknik, P. (2003). Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H145-H153.
61. Kitazawa, T., Asakawa, K., Nakamura, T., Teraoka, H., Unno, T., Komori, S., Yamada, M., and Wess, J. (2009). M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice. J. Pharmacol. Exp. Ther. 330, 487-493.
62. Kleber, A. G. (2000). The fibrillating atrial myocardium. What can the detection of wave breaks tell us? Cardiovasc. Res. 48, 181-184.
63. Klein, I., and Ojamaa, K. (2001). Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501-509.
64. Ko, J. K., Choi, K. H., Kim, I. S., Jung, E. K., and Park, D. H. (2001). Inducible RGS2 is a cross-talk regulator for parathyroid hormone signaling in rat osteoblast-like UMR106 cells. Biochem. Biophys. Res. Commun. 287, 1025-1033.
65. Kovoor, P., Wickman, K., Maguire, C. T., Pu, W., Gehrmann, J., Berul, C. I., and Clapham, D. E. (2001). Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J. Am. Coll. Cardiol. 37, 2136-2143.
66. Krejci, A., and Tucek, S. (2002). Quan-titation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Mol. Pharmacol. 61, 1267-1272.
67. Lazar, S., Dixit, S., Callans, D. J., Lin, D., Marchlinski, F. E., and Gerstenfeld, E. P. (2006). Effect of pulmonary vein isolation on the left-to-right atrial dominant frequency gradient in human atrial fibrillation. Heart Rhythm 3, 889-895.
68. Li, G. R., Wang, H. B., Qin, G. W., Jin, M. W., Tang, Q., Sun, H. Y., Du, X. L., Deng, X. L., Zhang, X. H., Chen, J. B., Chen, L., Xu, X. H., Cheng, L. C., Chiu, S. W., Tse, H. F., Vanhoutte, P. M., and Lau, C. P. (2008). Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation 117, 2449-2457.
69. Liu, L., and Nattel, S. (1997). Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am. J. Physiol. 273(Pt 2), H805-H816.
70. Lomax, A. E., Rose, R. A., and Giles, W. R. (2003). Electrophysiological evidence for a gradient of G protein-gated K+ current in adult mouse atria. Br. J. Pharmacol. 140, 576-584.
71. Machida, T., Hashimoto, N., Kuwa-hara, I., Ogino, Y., Matsuura, J., Yamamoto, W., Itano, Y., Zamma, A., Matsumoto, R., Kamon, J., Kobayashi, T., Ishiwata, N., Yamashita, T., Ogura, T., and Nakaya, H. (2011). Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation. Circ. Arrhythm. Electrophysiol. 4, 94-102.
72. MacWilliam, J. A. (1887). Fibrillar contraction of the heart. J. Physiol. (Lond.) 8: 296.
73. Mandapati, R., Skanes, A., Chen, J., Berenfeld, O., and Jalife, J. (2000). Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 101, 194-199.
74. Mansour, M., Mandapati, R., Berenfeld, O., Chen, J., Samie, F. H., and Jalife, J. (2001). Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation 103, 2631-2636.
75. Mawe, G. M., Talmage, E. K., Lee, K. P., and Parsons, R. L. (1996). Expression of choline acetyltrans-ferase immunoreactivity in guinea pig cardiac ganglia. Cell Tissue Res. 285,281-286.
76. Milligan, G., and Kostenis, E. (2006). Heterotrimeric G-proteins: a short history. Br. J. Pharmacol. 147(Suppl. 1),S46-S55.
77. Moe, G. K. (1962). On the multiple wavelet hypothesis of atrial fibrillation. Arch. Int. Pharmacodyn. Ther. 40, 183-189.
78. Moe, G. K., and Abildskov, J. A. (1959). Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am. Heart J. 58, 59-70.
79. Moe, G. K., Rheinboldt, W C, and Abildskov, J. A. (1964). A computer model of atrial fibrillation. Am. HeartJ. 67, 200-220.
80. Morillo, C. A., Klein, G. J., Jones, D. L., and Guiraudon, C. M. (1995). Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91, 1588-1595.
81. Nademanee, K., McKenzie, J., Kosar, E., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., and Ngarmukos, T. (2004). A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 43, 2044-2053.
82. Nakagawa, H., Sherlag, B. J., Lockwood, D., Wolf, R. K., Peyton, M., Wu, R., Yokoyama, K., Po, S. S., Herring, L., Lazzara, R., Jackmann, W. K., and Armour, J. A. (2005a). Localization of left atrial gamglionated plexuses using endocardial and epi-cardial high frequency stimulation in patients with atrial fibrillation. Heart Rhythm 2, S10-S11.
83. Nakagawa, H., Sherlag, B. J., Wu, A. W., Lockwood, D., Yokoyama, K., Herring, L., Lazzara, R., and Jackman, W. M. (2005b). Addition of selective ablation of autonomic ganglia to pulmonary vein antrum ablation for treatment of paroxysmal and persistent atrial fibrillation. Circulation 110, III-543.
84. Nattel, S. (2002). New ideas about atrial fibrillation 50 years on. Nature 415, 219-226.
85. Nattel, S. (2004). Age, gender, and supraventricular arrhythmias: roles of ion channels, connexins, and tissue architecture? Heart Rhythm 1, 397-398.
86. Nattel, S., Allessie, M., and Haissaguerre, M. (2002). Spotlight on atrial fibrillation-the "complete arrhythmia." Cardiovasc. Res. 54, 197-203.
87. Nishida, K., Maguy, A., Sakabe, M., Comtois, P., Inoue, H., and Nattel, S. (2011). The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation. Cardiovasc. Res. 89, 825-833.
88. Nixon, J. V. (2011). The AHA Clinical Cardiac Consult. Philadelphia: Lippincott Williams & Wilkins.
89. Noujaim, S. F., Lucca, E., Munoz, V., Persaud, D., Berenfeld, O., Meijler, E L., and Jalife, J. (2004). From mouse to whale: a universal scaling relation for the PR interval of the electrocardiogram of mammals. Circulation 110, 2802-2808.
90. Nygren, A., Lomax, A. E., and Giles, W. R. (2004). Heterogeneity of action potential durations in isolated mouse left and right atria recorded using voltage-sensitive dye mapping. Am. J. Physiol. Heart Circ. Physiol. 287, H2634-H2643.
91. Oliveira-dos-Santos, A. J., Matsumoto, G., Snow, B. E., Bai, D., Houston, E P., Whishaw, I. Q., Mariathasan, S., Sasaki, T., Wakeham, A., Ohashi, P. S., Roder, J. C., Barnes, C. A., Siderovski, D. P., and Penninger, J. M. (2000). Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc. Natl. Acad. Sci. U.S.A. 97,12272-12277.
92. Pappone, C., Rosanio, S., Oreto, G., Toc-chi, M., Gugliotta, F., Vicedomini, G., Salvati, A., Dicandia, C., Mazzone, P., Santinelli, V., Gulletta, S., and Chierchia, S. (2000). Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102, 2619-2628.
93. Pappone, C., Santinelli, V., Manguso, E, Vicedomini, G., Gugliotta, F., Augello, G., Mazzone, P., Tortoriello, V., Landoni, G., Zangrillo, A., Lang, C., Tomita, T., Mesas, C., Mastella, E.,andAlfieri, O. (2004).Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109, 327-334.
94. Platt, M., Mandapati, R., Sherlag, B. J., Yamanashi, W. S., Nagakawa, H., Lazzara, R., and Jackman, W. M. (2004). Limiting the number and extend of radiofrequency applications to terminate atrial fibrillation and subsequently prevent its inducibility. Heart Rhythm. 1, S11.
95. Roman, D. L., Ota, S., and Neubig, R. R. (2009). Polyplexed flow cytome-try protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors. J. Biomol. Screen. 14, 610-619.
96. Rosiak, M., Dziuba, M., Chudzik, M., Cygankiewicz, I., Bartczak, K., Drozdz, J., and Wranicz, J. K. (2010). Risk factors for atrial fibrillation: not always severe heart disease, not always so "lonely." Cardiol J. 17, 437-442.
97. Roy, A. A., Baragli, A., Bernstein, L. S., Hepler, J. R., Hebert, T. E., and Chidiac, P. (2006a). RGS2 interacts with Gs and adenylyl cyclase in living cells. Cell. Signal. 18, 336-348.
98. Roy, A. A., Nunn, C., Ming, H., Zou, M. X., Penninger, J., Kirshen-baum, L. A., Dixon, S. J., and Chidiac, P. (2006b). Up-regulation of endogenous RGS2 mediates cross-desensitization between Gs and Gq signaling in osteoblasts. J. Biol. Chem. 281, 32684-32693.
99. Roy, A. A., Lemberg, K. E., and Chidiac, P. (2003). Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol. Pharmacol. 64, 587-593.
100. Sakamoto, S., Schuessler, R. B., Lee, A. M., Aziz, A., Lall, S. C., and Dami-ano, R. J. Jr. (2010). Vagal denervation and reinnervation after ablation of ganglionated plexi. J. Thorac. Cardiovasc. Surg. 139, 444-452.
101. Salim, S., Sinnarajah, S., Kehrl, J. H., and Dessauer, C. W. (2003). Identification of RGS2 and type V adenylyl cyclase interaction sites. J. Biol. Chem. 278, 15842-15849.
102. Sarmast, F., Kolli, A., Zaitsev, A., Parisian, K., Dhamoon, A. S., Guha, P. K., Warren, M., Anumonwo, J. M., Taffet, S. M., Berenfeld, O., and Jalife, J. (2003). Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc. Res. 59, 863-873.
103. Savelieva, I., and Camm, A. J. (2001). Clinical trends in atrial fibrillation at the turn of the millenium. J. Intern. Med. 250, 369-372.
104. Scherlag, B. J., Patterson, E., and Po, S. S. (2006). The neural basis of atrial fibrillation. J. Electro cardiol. 39(Suppl. 4), S180-S183.
105. Schotten, U., Verheule, S., Kirchhof, P., and Goette, A. (2011). Pathophys-iological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91, 265-325.
106. Shen, M. J., Choi, E. K., Tan, A. Y., Han, S., Shinohara, T., Maruyama, M., Chen, L. S., Shen, C., Hwang, C., Lin, S. F., and Chen, P. S. (2011). Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillation. Heart Rhythm 8, 583-589.
107. Shi, H., Wang, H., Yang, B., Xu, D., and Wang, Z. (2004). The M3 receptor-mediated K(+) current (IKM3), a G(q) protein-coupled K(+) channel. J. Biol. Chem. 279, 21774-21778.
108. Shi, H., Yang, B., Xu, D., Wang, H., and Wang, Z. (2003). Electrophysiological characterization of cardiac muscarinic acetylcholine receptors: different subtypes mediate different potassium currents. Cell. Physiol. Biochem. 13, 59-74.
109. Shiroshita-Takeshita, A., Sakabe, M., Haugan, K., Hennan, J. K., and Nattel, S. (2007). Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 115, 310-318.
110. Sinnarajah, S., Dessauer, C. W., Srikumar, D., Chen, J., Yuen, J., Yilma, S., Dennis, J. C., Morrison, E. E., Vodyanoy,V.,andKehrl,J.H. (2001). RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409, 1051-1055.
111. Skanes, A. C., Mandapati, R., Berenfeld, O., Davidenko, J. M., and Jalife, J. (1998). Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 98, 1236-1248.
112. Souza, M. V., Duarte, M. M., Coeli, C. M., and Vaisman, M. (2012). Atrial fibrillation and hyperthy-roidism: relation between transoe-sophageal markers of a thrombo-genic milieu and clinical risk factors for thromboembolism. Clin. Endocrinol. (Oxf.) 76, 448-453.
113. Tamargo, J., Caballero, R., Gomez, R., Valenzuela, C., and Delpon, E. (2004). Pharmacology of cardiac potassium channels. Cardiovasc. Res. 62, 9-33.
114. Tank, J., Obst, M., Diedrich, A., Brychta, R. J., Blumer, K. J., Heusser, K., Jordan, J., Luft, F. C., and Gross, V. (2007). Sympathetic nerve traffic and circulating norepinephrine levels in RGS2-deficient mice. Auton. Neurosci. 136, 52-57.
115. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. (1989). Preliminary report: effect of encainide, and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J Med. 321, 406-412.
116. Thibodeau, I. L., Xu, J., Li, Q., Liu, G., Lam, K., Veinot, J. P., Birnie, D. H., Jones, D. L., Krahn, A. D., Lemery, R., Nicholson, B. J., and Gollob, M. H. (2010). Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a con-nexin 43-deletion mutant identified from atrial tissue. Circulation 122, 236-244.
117. Thijssen, V. L., Ausma, J., Liu, G. S., Allessie, M. A., Van Eys, G. J., and Borgers, M. (2000). Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc. Pathol. 9, 17-28.
118. Tovey, S. C., and Willars, G. B. (2004). Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor. Mol. Pharmacol. 66, 1453-1464.
119. Tsang, S., Woo, A. Y., Zhu, W., and Xiao, R. P. (2010). Deregulation of RGS2 in cardiovascular diseases. Front. Biosci. (Schol. Ed.) 2, 547-557.
120. Tseng, C. C., and Zhang, X. Y. (1998). Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor. Endocrinology 139, 4470-4475.
121. Tuomi, J. M., Chidiac, P., and Jones, D. L. (2010). Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. Am. I Physiol. Heart Circ. Physiol. 298, H554-H561.
122. Tuomi, J. M., Tyml, K., and Jones, D. L. (2011). Atrial tachycardia/fibrillation in the connexin 43 G60S mutant (Oculodentodigital dysplasia) mouse. Am. J. Physiol. Heart Circ. Physiol. 300, H1402-H1411.
123. Vaquero, M., Calvo, D., and Jalife, J. (2008). Cardiac fibrillation: from ion channels to rotors in the human heart. Heart Rhythm 5, 872-879.
124. Voigt, N., Trausch, A., Knaut, M., Matschke, K., Varro, A., Van Wagoner, D. R., Nattel, S., Ravens, U., and Dobrev, D. (2010). Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ. Arrhythm. Electro-physiol. 3, 472-480.
125. Vulpain, A. (1874). Note sur les effets de la faradisation directe des ventricu-laes du coeur le chien. Arch. Physiol. i, 975.
126. Wakili, R., Voigt, N., Kaab, S., Dobrev, D., and Nattel, S. (2011). Recent advances in the molecular patho-physiology of atrial fibrillation. J Clin. Invest. 121, 2955-2968.
127. Wang, H., Lu, Y., and Wang, Z. (2007a). Function of cardiac M3 receptors. Auton. Autacoid. Pharmacol. 27, 1-11.
128. Wang, X., Zeng, W., Kim, M. S., Allen, P. B., Greengard, P., and Muallem, S. (2007b). Spinophilin/neurabin reciprocally regulate signaling intensity by G protein-coupled receptors. EMBO J.26, 2768-2776.
129. Wang, T. L., Tseng, Y. Z., and Chang, H. (2000). Regulation of connexin 43 gene expression by cyclical mechanical stretch in neonatal rat cardiomyocytes. Biochem. Biophys. Res. Commun. 267, 551-557.
130. Wang, Z., Shi, H., and Wang, H. (2004). Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br. J. Pharmacol. 142, 395-408.
131. Wieland, T., Lutz, S., and Chidiac, P. (2007). Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system. Curr. Opin. Pharmacol. 7, 201-207.
132. Yamada, S., Maruyama, S., Takagi, Y., Uchida, S., and Oki, T. (2006). In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci. 80, 127-132.
133. Yamazaki, M., Vaquero, L. M., Hou, L., Campbell, K., Zlochiver, S., Klos, M., Mironov, S., Berenfeld, O., Honjo, H., Kodama, I., Jalife, J., and Kalifa, J. (2009). Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adreno-cholinergic stimulation: interplay between rotors and focal discharges. Heart Rhythm 6, 1009-1017.
134. Yan, G. X., and Kowey, P. R. (2011). Management of Cardiac Arrhythmias. New York: Humana Press.
135. Yeh, Y. H., Qi, X., Shiroshita-Takeshita, A., Liu, J., Maguy, A., Chartier, D., Hebert, T., Wang, Z., and Nattel, S. (2007). Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes. Br. J. Pharmacol. 152, 1021-1032.
136. Yue, P., Zhang, Y., Du, Z., Xiao, J., Pan, Z., Wang, N., Yu, H., Ma, W.,Qin, H., Wang, W. H., Lin, D. H., and Yang, B. (2006). Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes. Cell. Physiol. Biochem. 17, 129-136.
137. Zhang, W., Anger, T., Su, J., Hao, J., Xu, X., ZHU, M., Gach, A., Cui, L., Liao, R., and Mende, U. (2006). Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J. Biol. Chem. 281, 5811-5820.
138. Zhao, Q., Huang, C., Jiang, H., Okello, E., Tang, Y. H., Wang, Z., and Wu, Z. (2008). M2 and M3-muscarinic acetylcholine receptors remodelling in patients with a dilated atrium. Acta Cardiol 63,166-170.
139. Zipes, D. P. (1997). The seventh annual Gordon K. Moe Lecture. Atrial fibrillation: from cell t bedside. J. Cardiovasc. Electrophysiol. 8, 927-938.
140. Zipes, D. P., Mihalick, M. J., and Robbins, G. T. (1974). Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness. Cardiovasc. Res. 8, 647-655.
141. Zou, M. X., Roy, A. A., Zhao, Q., Kirshenbaum, L. A., Karmazyn, M., and Chidiac, P. (2006). RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes. Cell. Signal. 18, 1655-1663